{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:30:26Z","timestamp":1794004226049,"version":"4.8.0"},"reference-count":93,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["20\/FFPP\/8649"],"award-info":[{"award-number":["20\/FFPP\/8649"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["FUSP-PPC-24\\u2013082"],"award-info":[{"award-number":["FUSP-PPC-24\\u2013082"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014750","name":"Universidad San Pablo - CEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.csbj.2025.12.023","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:07:35Z","timestamp":1767028055000},"page":"235-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Network pharmacology of cellular targets in major depressive disorder and differential mechanisms of fluoxetine, ketamine and esketamine"],"prefix":"10.34133","volume":"31","author":[{"given":"Silvia","family":"Tapia-Gonzalez","sequence":"first","affiliation":[{"name":"Grupo de Neurofisiolog\u00eda Celular, Departamento de Ciencias M\u00e9dicas B\u00e1sicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio D\u00edez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Urbanizaci\u00f3n Montepr\u00edncipe s\/n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9 Garc\u00eda","family":"Yag\u00fce","sequence":"additional","affiliation":[{"name":"Grupo de Neurofisiolog\u00eda Celular, Departamento de Ciencias M\u00e9dicas B\u00e1sicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio D\u00edez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Urbanizaci\u00f3n Montepr\u00edncipe s\/n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Barreto","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Limerick, Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"e_1_3_5_2_2","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui L.","year":"2024","unstructured":"Cui L., Li S., Wang S., Wu X., Liu Y., Yu W. et al: Major depressive disorder: hypothesis, mechanism, prevention and treatment. Sig Transduct Target Ther 2024; 9.","journal-title":"Sig Transduct Target Ther"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03769-9"},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1461145712000016","article-title":"Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects","volume":"16","author":"Duric V.","year":"2013","unstructured":"Duric V., Banasr M., Stockmeier C.A., Simen A.A., Newton S.S., Overholser J.C. et al: Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol 2013; 16: 69.","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2886"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00210","article-title":"Glucocorticoid-driven NLRP3 inflammasome activation in Hippocampal Microglia mediates chronic stress-induced depressive-like Behaviors","volume":"12","author":"Feng X.","year":"2019","unstructured":"Feng X., Zhao Y., Yang T., Song M., Wang C., Yao Y. et al: Glucocorticoid-driven NLRP3 inflammasome activation in Hippocampal Microglia mediates chronic stress-induced depressive-like Behaviors. Front Mol Neurosci 2019; 12.","journal-title":"Front Mol Neurosci"},{"key":"e_1_3_5_7_2","article-title":"Microglia-Derived Interleukin-6 triggers astrocyte apoptosis in the hippocampus and mediates depression-like behavior","volume":"12","author":"Shen S.","year":"2025","unstructured":"Shen S., Liang L., Shi T., Shen Z., Yin S., Zhang J. et al: Microglia-Derived Interleukin-6 triggers astrocyte apoptosis in the hippocampus and mediates depression-like behavior. Adv Sci. 2025; 12.","journal-title":"Adv Sci."},{"key":"e_1_3_5_8_2","article-title":"Functions of p38 MAP Kinases in the Central Nervous System","volume":"13","author":"Asih P.R.","year":"2020","unstructured":"Asih P.R., Prikas E., Stefanoska K., Tan A.R.P., Ahel H.I. and Ittner A.: Functions of p38 MAP Kinases in the Central Nervous System. Front Mol Neurosci 2020; 13.","journal-title":"Front Mol Neurosci"},{"key":"e_1_3_5_9_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105900","article-title":"An overview of the relationship between inflammation and cognitive function in humans, molecular pathways and the impact of nutraceuticals","volume":"181","author":"Mekhora C.","year":"2024","unstructured":"Mekhora C., Lamport D.J. and Spencer J.P.E.: An overview of the relationship between inflammation and cognitive function in humans, molecular pathways and the impact of nutraceuticals. Neurochem Int 2024; 181: 105900.","journal-title":"Neurochem Int"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2005.08.017"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00510-06"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1698"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2174\/138161209788168100","article-title":"Opiates as antidepressants","volume":"15","author":"Berrocoso E.","year":"2009","unstructured":"Berrocoso E., S\u00e1nchez-Bl\u00e1zquez P., Garz\u00f3n J. and Mico J.A.: Opiates as antidepressants. Curr Pharm Des 2009; 15: 1612.","journal-title":"Curr Pharm Des"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.10.011"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.11.002"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archpsyc.63.11.1199","article-title":"Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women","volume":"63","author":"Kennedy S.E.","year":"2006","unstructured":"Kennedy S.E., Koeppe R.A., Young E.A. and Zubieta J.-K.: Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 2006; 63: 1199.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02814-z"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1474-9728.2003.00046.x"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/978-3-031-73368-0_33","volume-title":"Handbook of the Biology and Pathology of Mental Disorders","author":"Islam Md.R.","year":"2025","unstructured":"Islam Md.R., Roknuzzaman A.S.M., Sarker R., Haque Md.A., Qusar M.M.A.S. and Kabir E.R.: Neurotrophic Factor: Epidermal Growth Factor (EGF) and Depressive Disorder. In: Handbook of the Biology and Pathology of Mental Disorders. Edited by C.R. Martin, V.R. Preedy, V.B. Patel and R. Rajendram. Cham: Springer Nature Switzerland 2025: 847."},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare A.","year":"2015","unstructured":"Cleare A., Pariante C., Young A., Anderson I., Christmas D., Cowen P. et al: Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol 2015; 29: 459.","journal-title":"J Psychopharmacol"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: From monoamines to glutamate","volume":"23","author":"Hillhouse T.M.","year":"2015","unstructured":"Hillhouse T.M. and Porter J.H.: A brief history of the development of antidepressant drugs: From monoamines to glutamate. Exp Clin Psychopharmacol 2015; 23: 1.","journal-title":"Exp Clin Psychopharmacol"},{"key":"e_1_3_5_22_2","unstructured":"Pinna G. Fluoxetine: Pharmacology mechanisms of action and potential side effects. Nova Science Pub Inc 2015."},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman R.M.","year":"2000","unstructured":"Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S. et al: Antidepressant effects of ketamine in depressed patients. 351\u20134. Biol Psychiatry 2000; 47.","journal-title":"Biol Psychiatry"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000542-199704000-00021","article-title":"Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors","volume":"86","author":"Orser B.A.","year":"1997","unstructured":"Orser B.A., Pennefather P.S. and MacDonald J.F.: Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 1997; 86: 903.","journal-title":"Anesthesiology"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4050"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.255"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01629-w"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1190287"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.12.015"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial","volume":"75","author":"Daly E.J.","year":"2018","unstructured":"Daly E.J., Singh J.B., Fedgchin M., Cooper K., Lim P., Shelton R.C. et al: Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry 2018; 75: 139.","journal-title":"JAMA Psychiatry"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030727"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05245.x"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.3390\/ijms25115803","article-title":"Roles of Cytokines in Alzheimer\u2019s Disease","volume":"25","author":"Chen Z.","year":"2024","unstructured":"Chen Z., Balachandran Y.L., Chong W.P. and Chan K.W.Y.: Roles of Cytokines in Alzheimer\u2019s Disease. IJMS 2024; 25: 5803.","journal-title":"IJMS"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.npp.1300439","article-title":"In Vivo Regulation of Glycogen Synthase Kinase-3\u03b2 (GSK3\u03b2) by Serotonergic Activity in Mouse Brain","volume":"29","author":"Li X.","year":"2004","unstructured":"Li X., Zhu W., Roh M.-S., Friedman A.B., Rosborough K. and Jope R.S.: In Vivo Regulation of Glycogen Synthase Kinase-3\u03b2 (GSK3\u03b2) by Serotonergic Activity in Mouse Brain. Neuropsychopharmacol 2004; 29: 1426.","journal-title":"Neuropsychopharmacol"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.128"},{"key":"e_1_3_5_36_2","article-title":"Fluoxetine Regulates Neurogenesis In Vitro Through Modulation of GSK-3 \/ -Catenin Signaling","volume":"18","author":"Hui J.","year":"2015","unstructured":"Hui J., Zhang J., Kim H., Tong C., Ying Q., Li Z. et al: Fluoxetine Regulates Neurogenesis In Vitro Through Modulation of GSK-3 \/ -Catenin Signaling. pyu099\u2013pyu099 Int J Neuropsychopharmacol 2015; 18.","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000356517"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S1461145705005766","article-title":"Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions","volume":"9","author":"Molteni R.","year":"2006","unstructured":"Molteni R., Calabrese F., Bedogni F., Tongiorgi E., Fumagalli F., Racagni G. et al: Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions. Int J Neuropsychopharm 2006; 9: 307.","journal-title":"Int J Neuropsychopharm"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","first-page":"13098","DOI":"10.3390\/ijms252313098","article-title":"Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: a review","volume":"25","author":"Pardossi S.","year":"2024","unstructured":"Pardossi S., Fagiolini A. and Cuomo A.: Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: a review. IJMS 2024; 25: 13098.","journal-title":"IJMS"},{"key":"e_1_3_5_40_2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1073\/pnas.1916570117","article-title":"Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents","volume":"117","author":"Klein M.E.","year":"2020","unstructured":"Klein M.E., Chandra J., Sheriff S. and Malinow R.: Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents. Proc Natl Acad Sci USA 2020; 117: 2656.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac194"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.211"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1025"},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists","volume":"8","author":"Huang D.W.","year":"2007","unstructured":"Huang D.W., Sherman B.T., Tan Q., Collins J.R., Alvord W.G., Roayaei J. et al: The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 2007; 8.","journal-title":"Genome Biol"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad031","article-title":"Cytoscape.js 2023 update: a graph theory library for visualization and analysis","volume":"39","author":"Franz M.","year":"2023","unstructured":"Franz M., Lopes C.T., Fong D., Kucera M., Cheung M., Siper M.C. et al: Cytoscape.js 2023 update: a graph theory library for visualization and analysis. Bioinformatics 2023; 39: btad031.","journal-title":"Bioinformatics"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1235552","article-title":"Analysis of potential mechanism of Herbal Formula Taohong Siwu Decoction against vascular dementia based on network pharmacology and molecular docking","volume":"2023","author":"He R.","year":"2023","unstructured":"He R., He F., Hu Z., He Y., Zeng X., Liu Y. et al: Analysis of potential mechanism of Herbal Formula Taohong Siwu Decoction against vascular dementia based on network pharmacology and molecular docking. BioMed Res Int 2023; 2023: 1235552.","journal-title":"BioMed Res Int"},{"key":"e_1_3_5_48_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2024.07.023","article-title":"Molecular mechanisms of Schisandra chinensis in treating depression-neuropathic pain comorbidity by network pharmacology and molecular docking analysis","volume":"555","author":"Mokhtari T.","year":"2024","unstructured":"Mokhtari T. and EL-Meghawry EL-Kenawy A.: Molecular mechanisms of Schisandra chinensis in treating depression-neuropathic pain comorbidity by network pharmacology and molecular docking analysis. Neuroscience 2024; 555: 92.","journal-title":"Neuroscience"},{"key":"e_1_3_5_49_2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader G.D.","year":"2003","unstructured":"Bader G.D. and Hogue C.W.: An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinforma 2003; 4.","journal-title":"BMC Bioinforma"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1272"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","DOI":"10.4137\/GRSB.S702","article-title":"Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks","volume":"2","author":"Kosch\u00fctzki D.","year":"2008","unstructured":"Kosch\u00fctzki D. and Schreiber F.: Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks. Gene Regul Syst Bio 2008; 2: GRSB.S702.","journal-title":"Gene Regul Syst Bio"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1013"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-1524-3"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.05.047"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709990575"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01987.x"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2011.11.004"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.12.010"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.5"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.06.002"},{"key":"e_1_3_5_61_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-024-03126-0","article-title":"Novel therapeutic targets for major depressive disorder related to oxidative stress identified by integrative multi-omics and multi-trait study","volume":"14","author":"Shao X.","year":"2024","unstructured":"Shao X., Wang Y., Geng Z., Liang G., Zhu X., Liu L. et al: Novel therapeutic targets for major depressive disorder related to oxidative stress identified by integrative multi-omics and multi-trait study. Transl Psychiatry 2024; 14.","journal-title":"Transl Psychiatry"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.4.876"},{"key":"e_1_3_5_63_2","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.11.1.49","article-title":"Analysis of the epidermal growth factor receptor promoter: The effect of nuclear factor-\u03baB","author":"Nishi H.","year":"2003","unstructured":"Nishi H., Neta G., Nishi K., Akers L., Rikiyama T., Proctor K. et al: Analysis of the epidermal growth factor receptor promoter: The effect of nuclear factor-\u03baB. Int J Mol Med 2003; .","journal-title":"Int J Mol Med"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011021200"},{"key":"e_1_3_5_65_2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/sj.onc.1201731","article-title":"Epidermal growth factor activation of NF-\u03baB is mediated through I\u03baB\u03b1 degradation and intracellular free calcium","volume":"16","author":"Sun L.","year":"1998","unstructured":"Sun L. and Carpenter G.: Epidermal growth factor activation of NF-\u03baB is mediated through I\u03baB\u03b1 degradation and intracellular free calcium. Oncogene 1998; 16: 2095.","journal-title":"Oncogene"},{"key":"e_1_3_5_66_2","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.2028","article-title":"Role of I\u03baB\u03b1 as a negative regulator of EGFR and a molecular determinant of prognosis in glioblastoma multiforme","volume":"27","author":"Bredel M.","year":"2009","unstructured":"Bredel M., Renfrow J., Yadav A., Alvarez A., Lin D., Scholtens D. et al: Role of I\u03baB\u03b1 as a negative regulator of EGFR and a molecular determinant of prognosis in glioblastoma multiforme. 2028\u20132028 JCO 2009; 27.","journal-title":"JCO"},{"key":"e_1_3_5_67_2","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2015-LB-029","article-title":"Abstract LB-029: Signal transduction in EGFR-amplified and NFKBIA-deleted human gliomas","volume":"75","author":"Mishra A.","year":"2015","unstructured":"Mishra A., Kong J. and Brat D.J.: Abstract LB-029: Signal transduction in EGFR-amplified and NFKBIA-deleted human gliomas. LB-029-LB-029 Cancer Res 2015; 75.","journal-title":"Cancer Res"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.3.1266"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri910"},{"key":"e_1_3_5_70_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2024.02.014","article-title":"Sp1 Regulates the M1 Polarization of Microglia Through the HuR\/NF-\u03baB Axis after Spinal Cord Injury","volume":"544","author":"Guo H.","year":"2024","unstructured":"Guo H., Du M., Yang Y., Lin X., Wang Y., Li H. et al: Sp1 Regulates the M1 Polarization of Microglia Through the HuR\/NF-\u03baB Axis after Spinal Cord Injury. Neuroscience 2024; 544: 50.","journal-title":"Neuroscience"},{"key":"e_1_3_5_71_2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/mol.111.076620","article-title":"Mechanisms of the Inhibition of Nuclear Factor-\u03baB by Morphine in Neuronal Cells","volume":"81","author":"B\u00f6rner C.","year":"2012","unstructured":"B\u00f6rner C., H\u00f6llt V. and Kraus J.: Mechanisms of the Inhibition of Nuclear Factor-\u03baB by Morphine in Neuronal Cells. Mol Pharmacol 2012; 81: 587.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_5_72_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.psychres.2016.04.120","article-title":"Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders","volume":"241","author":"Miklowitz D.J.","year":"2016","unstructured":"Miklowitz D.J., Portnoff L.C., Armstrong C.C., Keenan-Miller D., Breen E.C., Muscatell K.A. et al: Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders. Psychiatry Res 2016; 241: 315.","journal-title":"Psychiatry Res"},{"key":"e_1_3_5_73_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0043-107033","article-title":"Comparing the Immune-Genomic Effects of Vilazodone and Paroxetine in Late-Life Depression: A Pilot Study","volume":"50","author":"Eyre H.","year":"2017","unstructured":"Eyre H., Siddarth P., Cyr N., Yang H., Cole S., Forbes M. et al: Comparing the Immune-Genomic Effects of Vilazodone and Paroxetine in Late-Life Depression: A Pilot Study. Pharmacopsychiatry 2017; 50: 256.","journal-title":"Pharmacopsychiatry"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0316-9"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104800"},{"key":"e_1_3_5_76_2","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.3390\/jcm10184064","article-title":"Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders\u2014Longitudinal Study in Adolescent and Young Adult Patients","volume":"10","author":"Skibinska M.","year":"2021","unstructured":"Skibinska M., Kapelski P., Dmitrzak-Weglarz M., Lepczynska N., Pawlak J., Twarowska-Hauser J. et al: Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders\u2014Longitudinal Study in Adolescent and Young Adult Patients. JCM 2021; 10: 4064.","journal-title":"JCM"},{"key":"e_1_3_5_77_2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.102.044834","article-title":"Fluoxetine Increases GABAA Receptor Activity through a Novel Modulatory Site","volume":"304","author":"Robinson R.T.","year":"2003","unstructured":"Robinson R.T., Drafts B.C. and Fisher J.L.: Fluoxetine Increases GABAA Receptor Activity through a Novel Modulatory Site. J Pharmacol Exp Ther 2003; 304: 978.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713001648"},{"key":"e_1_3_5_79_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2005.10.075","article-title":"Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors","volume":"1067","author":"Yamauchi M.","year":"2006","unstructured":"Yamauchi M., Miyara T., Matsushima T. and Imanishi T.: Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors. Brain Res 2006; 1067: 164.","journal-title":"Brain Res"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890140410"},{"key":"e_1_3_5_81_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000054618","article-title":"Central 5-Hydroxytryptamine-2A Receptor Expression in Transgenic Mice Bearing a Glucocorticoid Receptor Antisense","volume":"73","author":"Cyr M.","year":"2001","unstructured":"Cyr M., Charbonneau C., Morissette M., Rochford J., Barden N. and Di Paolo T.: Central 5-Hydroxytryptamine-2A Receptor Expression in Transgenic Mice Bearing a Glucocorticoid Receptor Antisense. Neuroendocrinology 2001; 73: 37.","journal-title":"Neuroendocrinology"},{"key":"e_1_3_5_82_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000341442","article-title":"Ketamine Inhibits Lipopolysaccharide-Induced Astrocytes Activation by Suppressing TLR4\/NF-?B Pathway","volume":"30","author":"Wu Y.","year":"2012","unstructured":"Wu Y., Li W., Zhou C., Lu F., Gao T., Liu Y. et al: Ketamine Inhibits Lipopolysaccharide-Induced Astrocytes Activation by Suppressing TLR4\/NF-?B Pathway. Cell Physiol Biochem 2012; 30: 609.","journal-title":"Cell Physiol Biochem"},{"key":"e_1_3_5_83_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/fcp.12508","article-title":"Ketamine inhibits LPS-mediated BV2 microglial inflammation via NMDA receptor blockage","volume":"34","author":"Lu Y.","year":"2020","unstructured":"Lu Y., Ding X., Wu X. and Huang S.: Ketamine inhibits LPS-mediated BV2 microglial inflammation via NMDA receptor blockage. Fundamemntal Clin Pharma 2020; 34: 229.","journal-title":"Fundamemntal Clin Pharma"},{"key":"e_1_3_5_84_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115918","article-title":"Antidepressant mechanisms of ketamine\u2019s action: NF-\u03baB in the spotlight","volume":"218","author":"Soko\u0142owska P.","year":"2023","unstructured":"Soko\u0142owska P., Seweryn Karbownik M., J\u00f3\u017awiak-B\u0119benista M., Dobielska M., Kowalczyk E. and Wiktorowska-Owczarek A.: Antidepressant mechanisms of ketamine\u2019s action: NF-\u03baB in the spotlight. Biochem Pharmacol 2023; 218: 115918.","journal-title":"Biochem Pharmacol"},{"key":"e_1_3_5_85_2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3892\/etm.2013.930","article-title":"Ketamine exerts antidepressant effects and reduces IL-1\u03b2 and IL-6 levels in rat prefrontal cortex and hippocampus","volume":"5","author":"Yang C.","year":"2013","unstructured":"Yang C., Hong T., Shen J., Ding J., Dai X.-W., Zhou Z.-Q. et al: Ketamine exerts antidepressant effects and reduces IL-1\u03b2 and IL-6 levels in rat prefrontal cortex and hippocampus. Exp Ther Med 2013; 5: 1093.","journal-title":"Exp Ther Med"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.105"},{"key":"e_1_3_5_87_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1503\/jpn.110011","article-title":"A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health","volume":"37","author":"Beaulieu J.-M.","year":"2012","unstructured":"Beaulieu J.-M.: A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. Jpn 2012; 37: 7.","journal-title":"Jpn"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2016.02.003"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092270"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000242"},{"key":"e_1_3_5_91_2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism","volume":"175","author":"Williams N.R.","year":"2018","unstructured":"Williams N.R., Heifets B.D., Blasey C., Sudheimer K., Pannu J., Pankow H. et al: Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. AJP 2018; 175: 1205.","journal-title":"AJP"},{"key":"e_1_3_5_92_2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1139\/cjpp-2015-0429","article-title":"Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-D-aspartate and opioid receptors","volume":"94","author":"Haj-Mirzaian A.","year":"2016","unstructured":"Haj-Mirzaian A., Kordjazy N., Ostadhadi S., Amiri S., Haj-Mirzaian A. and Dehpour A.: Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-D-aspartate and opioid receptors. Can J Physiol Pharm 2016; 94: 599.","journal-title":"Can J Physiol Pharm"},{"key":"e_1_3_5_93_2","article-title":"Ketamine-induced static and dynamic functional connectivity changes are modulated by opioid receptors and biological sex in rats","author":"Grasso V.","year":"2025","unstructured":"Grasso V., Tennyson J., Airan R.D. and Di Ianni T.: Ketamine-induced static and dynamic functional connectivity changes are modulated by opioid receptors and biological sex in rats. Neuropsychopharmacol 2025; .","journal-title":"Neuropsychopharmacol"},{"key":"e_1_3_5_94_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jad.2014.03.020","article-title":"Effect of OPRM1 and stressful life events on symptoms of major depression in African American adolescents","volume":"162","author":"Swann G.","year":"2014","unstructured":"Swann G., Byck G.R., Dick D.M., Aliev F., Latendresse S.J., Riley B. et al: Effect of OPRM1 and stressful life events on symptoms of major depression in African American adolescents. J Affect Disord 2014; 162: 12.","journal-title":"J Affect Disord"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025005598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025005598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.12.023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:26:00Z","timestamp":1778012760000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.12.023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":93,"alternative-id":["10.1016\/j.csbj.2025.12.023"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.12.023","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network pharmacology of cellular targets in major depressive disorder and differential mechanisms of fluoxetine, ketamine and esketamine","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}